Table 1.
Data collected from all groups
| Patients | Age (years) | Sex | Underlying disease | Location of lesion/tooth extraction | Outcomes | |
|---|---|---|---|---|---|---|
| Group 1 | #1 | 57 | Female | Breast cancer | Mandible | No MRONJ |
| #2 | 56 | Male | Multiple myeloma | Maxilla | No MRONJ | |
| #3 | 77 | Male | Prostate cancer | Mandible | No MRONJ | |
| #4 | 66 | Female | Breast cancer | Mandible | MRONJ development | |
| #5 | 41 | Female | Breast cancer | Maxilla | No MRONJ | |
| #6 | 49 | Female | Breast cancer | Mandible | MRONJ development | |
| #7 | 70 | Female | Breast cancer | Mandible | No MRONJ | |
| Group 2 | #1 | 70 | Male | Multiple myeloma | Maxilla | No MRONJ |
| #2 | 73 | Male | Prostate cancer | Maxilla | No MRONJ | |
| #3 | 41 | Female | Breast cancer | Mandible | No MRONJ | |
| #4 | 56 | Male | Multiple myeloma | Mandible | No MRONJ | |
| #5 | 62 | Female | Breast cancer | Mandible | No MRONJ | |
| #6 | 51 | Female | Breast cancer | Maxilla | No MRONJ | |
| #7 | 57 | Female | Breast cancer | Maxilla | No MRONJ | |
| #8 | 57 | Female | Breast cancer | Mandible | No MRONJ | |
| Group 3 | #1 | 68 | Male | Multiple myeloma | Maxilla | MRONJ recurrence |
| #2 | 66 | Male | Multiple myeloma | Maxilla | Healing | |
| #3 | 91 | Male | Prostate cancer | Mandible | Healing | |
| #4 | 73 | Female | Breast cancer | Mandible | Healing | |
| #5 | 57 | Female | Breast cancer | Maxilla | Healing |